Motco Biomarin Pharmaceutical Inc Transaction History

Motco

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$86.68 - $100.3 $2,427 - $2,808	28 New	28 $2,000
Q2 2022 Aug 05, 2022	SELL	$71.48 - $86.85 $3,716 - $4,516	-52 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$71.87 - $131.03 $3,737 - $6,813	52 New	52 $4,000
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $2,956 - $3,973	-46 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$67.4 - $85.11 $14,491 - $18,298	-215 Reduced 82.38%	46 $3,000
Q2 2019 Aug 07, 2019	BUY	$80.35 - $93.9 $20,971 - $24,507	261 New	261 $22,000
Q4 2018 Feb 08, 2019	SELL	$80.14 - $106.07 $8,975 - $11,879	-112 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$93.92 - $105.72 $10,519 - $11,840	112 New	112 $11,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

Stay updated on Motco with notifications on news.